Shi VY - Search Results

1

The pan-JAK inhibitor delgocitinib in a cream formulation demonstrates dose response in chronic hand eczema in a 16-week randomized phase IIb trial.

Worm M, Thyssen JP, Schliemann S, Bauer A, Shi VY, Ehst B, Tillmann S, Korn S, Resen K, Agner T. Worm M, et al. Among authors: shi vy. Br J Dermatol. 2022 Jul;187(1):42-51. doi: 10.1111/bjd.21037. Epub 2022 Apr 19. Br J Dermatol. 2022. PMID: 35084738 Free PMC article. Clinical Trial.

2

The impact of airborne pollution on atopic dermatitis: a literature review.

Hendricks AJ, Eichenfield LF, Shi VY. Hendricks AJ, et al. Among authors: shi vy. Br J Dermatol. 2020 Jul;183(1):16-23. doi: 10.1111/bjd.18781. Epub 2020 Jan 15. Br J Dermatol. 2020. PMID: 31794065 Review.

3

Identifying triggers for hidradenitis suppurativa flare: a patient survey.

Thompson AM, Fernandez JM, Rick J, Hendricks AJ, Maarouf M, Mata EM, Collier EK, Grogan TR, Hsiao JL, Shi VY. Thompson AM, et al. Among authors: shi vy. Br J Dermatol. 2021 Jul;185(1):225-226. doi: 10.1111/bjd.19926. Epub 2021 May 4. Br J Dermatol. 2021. PMID: 33665807 No abstract available.

4

A new era of moisturizers.

Chandan N, Rajkumar JR, Shi VY, Lio PA. Chandan N, et al. Among authors: shi vy. J Cosmet Dermatol. 2021 Aug;20(8):2425-2430. doi: 10.1111/jocd.14217. Epub 2021 May 22. J Cosmet Dermatol. 2021. PMID: 33977643 Review.

5

Hidradenitis suppurativa: redirecting a life trajectory.

Hsiao J, Shi V. Hsiao J, et al. Br J Dermatol. 2021 Nov;185(5):878. doi: 10.1111/bjd.20696. Epub 2021 Sep 1. Br J Dermatol. 2021. PMID: 34468981 No abstract available.

6

Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND).

Shi VY, Bhutani T, Fonacier L, Deleuran M, Shumack S, Valdez H, Zhang F, Chan GL, Cameron MC, Yin NC. Shi VY, et al. J Am Acad Dermatol. 2022 Aug;87(2):351-358. doi: 10.1016/j.jaad.2022.04.009. Epub 2022 Apr 16. J Am Acad Dermatol. 2022. PMID: 35439608 Free article. Clinical Trial.

7

Bibliometric analysis of the 50 most cited publications in atopic dermatitis.

Thompson AM, Seivright J, Hsiao JL, Shi VY. Thompson AM, et al. Among authors: shi vy. Pediatr Dermatol. 2022 Jul;39(4):578-583. doi: 10.1111/pde.15027. Epub 2022 May 5. Pediatr Dermatol. 2022. PMID: 35510832

8

Comparing the effect of bleach and water baths on skin barrier function in atopic dermatitis: a split-body randomized controlled trial.

Shi VY, Foolad N, Ornelas JN, Hassoun LA, Monico G, Takeda N, Saric S, Prakash N, Eichenfield LF, Sivamani RK. Shi VY, et al. Br J Dermatol. 2016 Jul;175(1):212-4. doi: 10.1111/bjd.14483. Epub 2016 Jun 7. Br J Dermatol. 2016. PMID: 26875771 Clinical Trial. No abstract available.

9

Epithelial barrier dysfunctions in atopic dermatitis: a skin-gut-lung model linking microbiome alteration and immune dysregulation.

Zhu TH, Zhu TR, Tran KA, Sivamani RK, Shi VY. Zhu TH, et al. Among authors: shi vy. Br J Dermatol. 2018 Sep;179(3):570-581. doi: 10.1111/bjd.16734. Epub 2018 Jul 11. Br J Dermatol. 2018. PMID: 29761483 Review.

10

Current and emerging therapies for hand eczema.

Lee GR, Maarouf M, Hendricks AK, Lee DE, Shi VY. Lee GR, et al. Among authors: shi vy. Dermatol Ther. 2019 May;32(3):e12840. doi: 10.1111/dth.12840. Epub 2019 Feb 18. Dermatol Ther. 2019. PMID: 30693618 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

237 results

Search Page